Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 62Recruiting 23Unknown 22Terminated 15Active not recruiting 9Not yet recruiting 6Withdrawn 4Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 17Carcinoma, Renal Cell 3Skin Neoplasms 2Sarcoma 2Recurrence 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Basal Cell 2Triple Negative Breast Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomach Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Hypotension 1Gastrointestinal Stromal Tumors 1Eyelid Squamous Cell Carcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Brain Neoplasms 1Basal Cell Nevus Syndrome 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Carcinoma, Squamous Cell × Dermatologic × Clear all
NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

DNAtrix, Inc.

Phase 1 Suspended
30 enrolled
BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡